FDA allows temporary import of unapproved Chinese cancer drug to ease U.S. shortage

The FDA has given Qilu Pharmaceutical permission to ship cisplatin to the U.S. to ease a national cancer drug shortage.

from Health and Science https://ift.tt/d5kK7GM
https://ift.tt/uxY4LDB
https://ift.tt/mCWZPyf